Difficult-to-Control Type 2 Diabetes and a Post-Dexamethasone Suppression Test Cortisol of 1.2–1.8 µg/dL: Findings From a Large Prospective Study

Summary

  • While current guidelines recommend a post–1-mg DST cortisol cutoff of >1.8 μg/dL for hypercortisolism screening, a continuum of cardiometabolic risk appears to exist as a function of non-suppressible cortisol
  • Cardiac comorbidities and the use of glucose-lowering and antihypertensive medications among the participants with post-DST cortisol 1.2–1.8 μg/dL more closely resembled the subgroup with post-DST cortisol >1.8 μg/dL than the subgroup with post-DST cortisol <1.2 μg/dL
  • Further investigation of individuals with post-DST cortisol below 1.8 μg/dL is warranted, as they show similarities to those above the current hypercortisolism diagnostic cutoff

Download presentation

© 2025 Corcept Therapeutics, Incorporated

Privacy Notice | Terms of Use | Site Map | Your Privacy Choices | LinkedIn | Youtube

Privacy Notice

Terms of Use

Site Map

Your Privacy Choices

LinkedIn

Youtube